Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets open in the green
Tue, 24 Feb 09:30 am

Barring Hong Kong (down 0.6%), the major Asian stock markets have opened the day on a positive note with stock markets in China (up 0.8%) and Korea (up 0.6%) leading the gains. The Indian markets have opened in the green. Barring oil and gas and banking, all sectoral indices have opened in the green with the stocks in the FMCG and realty segment leading the gains.

BSE-Sensex is currently trading higher by about 42 points (up 0.1%), while the NSE-Nifty is higher by about 8 points (up 0.1%). Both midcap and small caps have opened firm with the BSE Mid Cap and BSE Small Cap indices up by 0.4% and 0.3% respectively. The rupee was trading at Rs 62.23 to the dollar.

Indian pharma stocks have opened the day mainly in the green with J.B Chemicals and Wockhardt Ltd leading the gains. As per a leading financial daily, the US Food and Drug Administration (FDA) has raised concerns over production processes at Lupin Ltd's Pithampur plant in Central India. The FDA had inspected the plant in January 2015, post which it issued the company Form 483, listing six observations on the manufacturing processes at the plant. In a Form 483, the FDA typically outlines conditions or practices at a drug-making unit that may cause the products made there to be in violation of the US agency's standard production requirements. The company has received one drug approval and two site-transfer approvals from the same plant since the FDA audit.

Automobile stocks have opened the day on a mixed note with Tube Investments Ltd and Force Motors Ltd leading the gains. However, Maharashtra Scooters Ltd and TVS Motors were facing selling pressure. As per a leading financial daily, Maruti Suzuki Ltd is planning to start a new range of premium dealerships across India to focus on sale of new niche models as the company aims to double its volume to two million cars in the next five years. While the dealerships will be operating under the Maruti Suzuki brand, these will be distinct from the current network of dealership across the country. These would cater to its high-end car segment where the company's presence is negligible. The new network would initially target big auto markets like Delhi and Mumbai with around 30 to 35 such new dealerships likely to come up in major cities in the next one year.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets open in the green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.